Oncolin Therapeutics, Inc.

Oncolin Therapeutics, Inc. (Oncolin Therapeutics), formerly Edgeline Holdings, Inc. operates in the healthcare division through its subsidiary Intertech Bio Corporation. The company is an early stage development company engaged in the development of products to treat cancer, medical disorders related to immune system, and other infectious diseases. Oncolin Therapeutics entered into optional agreements with the University of Texas MD Anderson Cancer Center and pharmaceutical research institute of Warsaw, Poland to facilitate and improve its research opportunities. Its research activities are mainly focused on developing drug candidates that interfere with the key mechanisms of tumor progression. The company has several products in its pipeline undergoing clinical trails that functions more effectively on solid tumors and cancer causing agents. Oncolin Therapeutics is headquartered in Texas, the US.

Street: 
5075 Westheimer
City: 
Bellaire
Postcode: 
77401
Federal State : 
United States
WebSite: 
www.oncolinthera.com

Company Index Score

Current Index Score Historical Index Score
  • Oncolin Therapeutics, Inc. currently scores 50 % in the index.
  • Oncolin Therapeutics, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Oncolin Therapeutics, Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets